Public Company News

HCLTech Q3 FY26 revenue up 4.2% QoQ (CC) as annualized revenue crosses $15B; bookings exceptionally high at $3B

Revenue guidance raised to 4.0% - 4.5% YoY CC, services revenue guidance to 4.75%-5.25% YoY CC NEW YORK and NOIDA, India, Jan. 13, 2026 /PRNewswire/ -- HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, delivered a strong performance for ...

2026-01-13 02:27 6782

Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications

Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market BEIJING, Jan. 12, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in aco...

2026-01-12 22:30 2312

HCLTech to partner with The Magnum Ice Cream Company to modernize its digital foundation

NOIDA, India, Jan. 12, 2026 /PRNewswire/ -- HCLTech  (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, has entered into a multi-year partnership to design, build and manage a future-ready IT infrastructure forThe Magnum Ice Cream Company (TMICC), ...

2026-01-12 22:23 5825

PlayNitride and Brillink Announce Strategic Collaboration to Advance Array-Based Photonic Interconnects

HSINCHU and MIAOLI, Jan. 12, 2026 /PRNewswire/ -- PlayNitride, a global leader in MicroLED technologies, today announced a strategic collaboration with Brillink to develop a next-generation array-based photonic interconnect solution designed to deliver longer reach, lower power consumption, and ...

2026-01-12 22:00 337

NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan's Healthcare Event

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Be...

2026-01-12 22:00 6711

Oriental Culture Holding LTD Announces Special Cash Dividend Plan to Reward Shareholders on Fifth Anniversary of Listing

Nasdaq: OCG NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Oriental Culture Holding LTD (Nasdaq: OCG) announced today that its Board of Directors has approved a special cash dividend plan to celebrate the company's fifth anniversary of listing on Nasdaq and reward shareholders for their long-term suppo...

2026-01-12 21:55 7428

Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease

CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ISM5411 (NCT07265570

2026-01-12 21:30 1581

DAR GLOBAL AND THE TRUMP ORGANISATION EXPAND SAUDI PORTFOLIO WITH USD 1BN TRUMP PLAZA JEDDAH

JEDDAH, Saudi Arabia, Jan. 12, 2026 /PRNewswire/ -- Dar Global (LSE: DAR), the London-listed international luxury real estate developer, announced today the official launch of Trump Plaza Jeddah, marking its third prestigious collaboration with The Trump Organization in Saudi Arabia. Valued at ov...

2026-01-12 21:10 6713

WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing

SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufactur...

2026-01-12 21:09 5021

CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors

SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveragin...

2026-01-12 21:05 3848

ECARX Holdings Inc. Announces US$45.6 million Strategic Investment from Geely Holding Group

LONDON, Jan. 12, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced that it has entered into a subscription agreement with Geely Investment Holding Ltd. ("Geely Holding") onJanuary 8th, 2026. Under the terms of the a...

2026-01-12 20:04 5149

Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion

HSK39004, a novel dual‑target therapy, aims to compete in the global COPD market, highlighting innovation and international capabilities BEIJING, Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an ex...

2026-01-12 20:00 2465

XCMG gets off to a flying start in 2026 with multiple deliveries to international markets

XUZHOU, China, Jan. 12, 2026 /PRNewswire/ -- XCMG Machinery (SHE: 000425) is starting 2026 on a high note with multiple batch deliveries of a wide range of products to customers both at home and abroad. The bulk shipments have embarked on their journey to Europe, North America, South Asia, the Mi...

2026-01-12 19:11 13033

Equity Acquisition of Nanyue Diankong (Hengyang) Industrial Technology

SINGAPORE, Jan. 12, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), wishes to announce tha...

2026-01-12 19:00 6440

Infosys and ATP Unveil 'Ally', an AI Chatbot to Elevate Fan Experience, and Announce Extension of Partnership Through 2028

Ally, powered by Infosys Topaz™, will further boost the tennis experience with humanized, intelligent fan interactions BENGALURU, India, Jan. 12, 2026 /PRNewswire/ -- Infosys  (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital servic...

2026-01-12 18:52 5557

TAL Education Group to Announce Third Quarter of Fiscal Year 2026 Financial Results on January 29, 2026

BEIJING, Jan. 12, 2026 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider inChina, today announced that it will release its unaudited financial results for the third quarter of fiscal year 2026 endedNovember 30, 2025,  before the market o...

2026-01-12 17:30 352

WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025

SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today issued a Positive Profit Alert for the full year of 2025, disclosing forecasts of key operational data...

2026-01-12 17:30 1624

CAYIN AI: Revolutionizing Creativity and Global Communication

TAIPEI, Jan. 12, 2026 /PRNewswire/ -- CAYIN Technology, the world's trusted provider of digital signage solutions, today announced a breakthrough update for SMP, CMS-WS, and CMS-SE. By embedding advanced AI into the signage ecosystem, CAYIN transforms how businesses create, translate, and manage ...

2026-01-12 16:34 8578

XPENG Charts New Course in 2026: Flagship Launch, Sales Momentum, and AI Breakthrough Propel Global Technology Ambitions

GUANGZHOU, China, Jan. 12, 2026 /PRNewswire/ -- XPENG is ushering in 2026 with transformative momentum, reinforcing its strategic evolution into an AI-driven global technology leader. The company unveiled its next-generation flagship model, celebrated a critical production milestone, and introduc...

2026-01-12 16:14 2865

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol...

2026-01-12 16:00 2545
1 ... 50515253545556 ... 1665

Week's Top Stories